Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography

Molecular imaging of a suicide transgene's expression will aid the development of efficient and precise targeting strategies, and imaging for cancer cell viability may assess therapeutic efficacy. We used the PET reporter probe, 9-(4-[18F]fluoro-3-(hydroxymethyl)butyl)guanine ([18F]FHBG) to monitor the expression of a mutant Herpes Simplex Virus 1 thymidine kinase (HSV1-sr39tk) in C6 glioma tumors implanted subcutaneously in nude mice that were repetitively being treated with the pro-drug Ganciclovir (GCV). [18F]-Fluorodeoxyglucose ([18F]FDG), a metabolic tracer, was used to assess tumor cell viability and therapeutic efficacy. C6 glioma tumors stably expressing the HSV1-sr39tk gene (C6sr39) accumulated [18F]FHBG prior to GCV treatment. Significant declines in C6sr39 tumor volumes and [18F]FHBG and [18F]FDG accumulation were observed following 2 weeks of GCV treatment. However, 3 weeks after halting GCV treatment, the tumors re-grew and [18F]FDG accumulation increased significantly; in contrast, tumor [18F]FHBG concentrations remained at background levels. Therefore, [18F]FHBG can be used to detect tumors expressing HSV1-sr39tk, susceptible to regression in response to GCV exposure, and the effectiveness of GCV therapy in eradicating HSV1-sr39tk-expressing cells can be monitored by [18F]FHBG scanning. [18F]FHBG and [18F]FDG imaging data indicate that exposure of C6sr39 tumors to GCV causes the elimination of [18F]FHBG-accumulating C6sr39 cells and selects for re-growth of tumors unable to accumulate [18F]FHBG.

[1]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  S. Gambhir.  Quantitation of the physical factors affecting the tracer kinetic modeling of cardiac positron emission tomography data , 1990 .

[3]  F. Gage,et al.  Thymidine kinase-mediated killing of rat brain tumors. , 1993, Journal of neurosurgery.

[4]  R.M. Leahy,et al.  Fully 3D Bayesian image reconstruction for the ECAT EXACT HR+ , 1997, 1997 IEEE Nuclear Science Symposium Conference Record.

[5]  Simon R. Cherry,et al.  Fully 3D Bayesian image reconstruction for the ECAT EXACT HR , 1997 .

[6]  R. Ramesh,et al.  Immune system in suicide-gene therapy , 1997, The Lancet.

[7]  G. van Kaick,et al.  Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Conti,et al.  Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. , 1998, Nuclear medicine and biology.

[9]  M. Iyo,et al.  Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapy. , 1998, Nuclear medicine and biology.

[10]  G. Brix,et al.  Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase , 1998, Gene Therapy.

[11]  S. Cherry,et al.  Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Humm,et al.  Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. , 1998, Cancer research.

[13]  T. A. Smith,et al.  FDG uptake, tumour characteristics and response to therapy: A review , 1998, Nuclear medicine communications.

[14]  S. Cherry,et al.  Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals , 1999, Gene Therapy.

[15]  J. Barrio,et al.  Assays for noninvasive imaging of reporter gene expression. , 1999, Nuclear medicine and biology.

[16]  M. Black,et al.  Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant , 1999, Gene Therapy.

[17]  S. Cherry,et al.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Wahl,et al.  Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. , 1999, Radiology.

[19]  N. Sadato,et al.  FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  S. Cherry,et al.  Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  S. Cherry,et al.  Quantification of target gene expression by imaging reporter gene expression in living animals , 2000, Nature Medicine.

[22]  Krzysztof P Bobinski,et al.  Seeing is believing: Non‐invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography , 2000, Journal of neuroscience research.

[23]  A. Lammertsma,et al.  Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods , 2000, European Journal of Nuclear Medicine.

[24]  Simon R. Cherry,et al.  Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET , 2000, IEEE Transactions on Medical Imaging.

[25]  S. Larson,et al.  Imaging transgene expression with radionuclide imaging technologies. , 2000, Neoplasia.

[26]  M. Black,et al.  A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Barrio,et al.  Monitoring gene therapy with reporter gene imaging. , 2001, Seminars in nuclear medicine.

[28]  M. Black,et al.  Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. , 2001, Cancer research.

[29]  Imaging Cellular Proliferation as a Measure of Response to Therapy , 2001, Journal of clinical pharmacology.

[30]  N. Satyamurthy,et al.  Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors , 2001, Gene Therapy.

[31]  N. Satyamurthy,et al.  8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  F. Floeth,et al.  Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma , 2001, Cancer Gene Therapy.

[33]  N. Satyamurthy,et al.  Quantitative imaging of gene induction in living animals , 2001, Gene Therapy.

[34]  J. Barrio,et al.  Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  A. Chatziioannou.  PET scanners dedicated to molecular imaging of small animal models. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[36]  J. Barrio,et al.  Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  Hisataka Kobayashi,et al.  Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  W. Fisher,et al.  Current Progress in Suicide Gene Therapy for Cancer , 2002, World Journal of Surgery.

[39]  石守 崇好.  Increased 18F-FDG uptake in a model of inflammation : Concanavalin A-mediated lymphocyte activation , 2003 .

[40]  S. Gambhir,et al.  Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  A. Reader,et al.  Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.